RT Journal Article SR Electronic T1 Estimating the Changing Infection Rate of COVID-19 Using Bayesian Models of Mobility JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.08.06.20169664 DO 10.1101/2020.08.06.20169664 A1 Liu, Luyang A1 Vikram, Sharad A1 Lao, Junpeng A1 Ben, Xue A1 D’Amour, Alexander A1 O’Banion, Shawn A1 Sandler, Mark A1 Saurous, Rif A. A1 Hoffman, Matthew D. YR 2020 UL http://medrxiv.org/content/early/2020/08/07/2020.08.06.20169664.abstract AB In order to prepare for and control the continued spread of the COVID-19 pandemic while minimizing its economic impact, the world needs to be able to estimate and predict COVID-19’s spread. Unfortunately, we cannot directly observe the prevalence or growth rate of COVID-19; these must be inferred using some kind of model. We propose a hierarchical Bayesian extension to the classic susceptible-exposed-infected-removed (SEIR) compartmental model that adds compartments to account for isolation and death and allows the infection rate to vary as a function of both mobility data collected from mobile phones and a latent time-varying factor that accounts for changes in behavior not captured by mobility data. Since confirmed-case data is unreliable, we infer the model’s parameters conditioned on deaths data. We replace the exponential-waiting-time assumption of classic compartmental models with Erlang distributions, which allows for a more realistic model of the long lag between exposure and death. The mobility data gives us a leading indicator that can quickly detect changes in the pandemic’s local growth rate and forecast changes in death rates weeks ahead of time. This is an analysis of observational data, so any causal interpretations of the model’s inferences should be treated as suggestive at best; nonetheless, the model’s inferred relationship between different kinds of trips and the infection rate do suggest some possible hypotheses about what kinds of activities might contribute most to COVID-19’s spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work is supported by Google LLC.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe use unprocessed COVID-19 case and death count numbers from the New York Times, which produces daily reports of new infections and deaths at both state and county level. For mobility, we use the Community Mobility Reports published by Google in our evaluation of Bayesian compartmental models. https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html https://www.google.com/covid19/mobility/